Radiological Associates of Sacramento and Radiant Sage LLC Launch New Venture
Launched by Radiological Associates of Sacramento (RAS) and Radiant Sage LLC in August, Impact Corelab, Inc. provides imaging corelab services specializing in oncology and neurology clinical trials for drug and device sponsors and clinical research organizations (CROs) wanting to outsource without compromising the need for transparency and control. The new firm, wholly owned by Radiant Sage and RAS, delivers best-of-breed cloud-based clinical image management solutions and specialized therapeutic expertise to provide benefits that include shorter trials, reduced risk and cost savings.
Among the specific services Impact Corelab provides are:
·Trial design and management including site, study, reader and data management;
·Clinical imaging science;
·Regulatory services; and
·A comprehensive, integrated technology support platform
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
